Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 7, 2004, Pages 793-798

  Marras, Theodore K ^a   Morris, Alison ^b   Gonzalez, Leah C ^b   Daley, Charles L ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

Guidelines; Mycobacterium infections, atypical; Survival analysis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ETHAMBUTOL; ISONIAZID; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; DIAGNOSTIC APPROACH ROUTE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MICROSCOPY; MORTALITY; MYCOBACTERIUM KANSASII; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM SMEAR; SURVIVAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, GENERAL; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SPUTUM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4644318003     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200402-162OC     Document Type: Article

References (22)

1. Marras TK, Daley CL. Systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (In press)
2. Campo RE, Campo CE. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997;24: 1233-1238.
3. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev Infect Dis 1991;13: 789-796.
4. Rooney G, Nelson MR, Gazzard B. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. J Clin Pathol 1996;49:821-823.
5. Santin M, Alcaide F. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy. Int J Tuberc Lung Dis 2003;7:673-677.
6. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-567.
7. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:861-868.
8. Valainis GT, Cardona LM, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquir Immune Defic Syndr 1991;4:516-520.
9. Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace PMJT, Greer DL, Hyslop NE Jr. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995;21:77-85.
10. Corbett EL, Blumberg L, Churchyard GJ, Moloi M, Mallory K, Clayton T, Williams BG, Chaisson RE, Hayes RJ, DeCock KM. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21.
11. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156: S1-S25.
12. Spradling P, Drociuk D, McLaughlin S, Lee LM, Peloquin CA, Gallicano K, Pozsik C, Onorato I, Castro KG, Ridzon R. Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak. Clin Infect Dis 2002;35:1106-1112.
13. Burman WJ, Gallicano K, Peloquin C. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Clin Infect Dis 1999;28:419-429.
14. Klein JL, Corbett EL, Slade PM, Miller RF, Coker RJ. Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect 1998;37:252-259.
15. Lortholary O, Deniel F, Boudon P, LePennec MP, Mathieu M, Soilleux M, LePendeven C, Loiseau P, Vincent V, Valeyre D. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Int J Tuberc Lung Dis 1999;3:68-73.
16. Pintado V, Gomez-Mampaso E, Martin-Davila P, Cobo J, Navas E, Quereda C, Fortun J, Guerrero A. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1999;18:582-586.
17. Marras TK, Gonzalez LC, Daley CL. Pulmonary Mycobacterium kansasii infection in human immunodeficiency virus infected individuals: diagnostic criteria and treatment in predicting survival [abstract]. Am J Respir Crit Care Med 2003;167:A708.
18. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis: II: accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503-1510.
19. Bamberger DM, Driks MR, Gupta MR, O'Connor MC, Jost PM, Neihart RE, McKinsey DS, Moore LA. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994;18:395-400.
20. Corbett EL, Churchyard GJ, Hay M, Herselman P, Clayton T. Williams B, Hayes R, Mulder D, De Cock KM. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 1999;160:10-14.
21. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, De Cock KM. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS 2000;14:2759-2768.
22. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 2000;19:1059-1079.